Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1984 Feb;51(2):377–385.

In vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. III. Spontaneous and natural cytotoxic effector cells.

A G Herbert, G S Le Gros, S Bidawid, J D Watson
PMCID: PMC1454437  PMID: 6607213

Abstract

Cytotoxic effector cell populations in murine spleen can be characterized by the phenotype of the cytotoxic cells or the nature of target cells. Lytic events can be antigen-specific, MHC-restricted and clonal, or target cell-specific but apparently non-MHC-restricted. Two cytotoxic effectors of this latter category are spontaneous and natural killers. Normal spleen cells from (BALB/c X DBA/2J)F1 mice (CDF1) cultured without added antigen develop a population of Thy-1+ spontaneous cytotoxic lymphocytes (SCTL) that lyse the DBA/2J mastocytoma P815, as well as the BALB/c-derived plasmacytomas MOPC-11 and SP2/0. Cold target competition experiments reveal the BALB/c-derived plasmacytomas MOPC-11, SP2/0, J558 and the A strain-derived T cell lymphoma YAC-1, but not normal lymphoblasts, block the lysis of P815 target cells. Thus, while these tumour cells appear to express common antigens which are recognized by SCTL cells, plasmacytomas such as J558 are not susceptible to lysis by SCTL. The relationship of SCTL to natural killer (NK) cells was examined. In-vivo treatment of mice with monoclonal anti-Thy-1 antibody leads to a rapid loss of SCTL and precursors from the spleen, but there is a concomitant increase in NK cell activity.

Full text

PDF
377

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartlett S. P., Burton R. C. Studies on natural killer (NK) cells. III. The effects of in vitro culture on spontaneous cytotoxicity of murine spleen cells. J Immunol. 1982 Mar;128(3):1070–1075. [PubMed] [Google Scholar]
  2. Bevan M. J. The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens. J Exp Med. 1975 Dec 1;142(6):1349–1364. doi: 10.1084/jem.142.6.1349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Botzenhardt U., Klein J., Ziff M. Primary in vitro cell-mediated lympholysis reaction of NZB mice against unmodified targets syngeneic at the major histocompatibility complex. J Exp Med. 1978 May 1;147(5):1435–1448. doi: 10.1084/jem.147.5.1435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Boyer P. J., Fahey J. L. Stimulation of lymphoid cells from normal and immune mice by syngeneic BALB/c plasma cell tumors. J Immunol. 1976 Jan;116(1):202–209. [PubMed] [Google Scholar]
  5. Burton R. C., Chism S. E., Warner N. L. In vitro induction of tumor specific immunity. VII. Does autosensitization occur with in vitro culture of T lymphocytes? J Immunol. 1977 Oct;119(4):1329–1339. [PubMed] [Google Scholar]
  6. Chen T. R. In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp Cell Res. 1977 Feb;104(2):255–262. doi: 10.1016/0014-4827(77)90089-1. [DOI] [PubMed] [Google Scholar]
  7. Ching L. M., Marbrook J., Walker K. Z. Spontaneous clones of cytotoxic T cells in culture. II. Specificity of the response. Cell Immunol. 1977 Jun 15;31(2):293–301. doi: 10.1016/0008-8749(77)90030-2. [DOI] [PubMed] [Google Scholar]
  8. Ching L. M., Walker K. Z., Marbrook J. Clones of cytotoxic lymphocytes in culture: the difference in specificity between stimulated and nonstimulated cytotoxic lymphocytes. Eur J Immunol. 1977 Dec;7(12):846–850. doi: 10.1002/eji.1830071205. [DOI] [PubMed] [Google Scholar]
  9. Chism S. E., Burton R. C., Grail D. L., Bell P. M., Warner N. L. In vitro induction of tumor-specific immunity. VI: analysis of specificity of immune response by cellular competitive inhibition: limitations and advantages of the technique. J Immunol Methods. 1977;16(3):245–262. doi: 10.1016/0022-1759(77)90202-2. [DOI] [PubMed] [Google Scholar]
  10. Chism S. E., Burton R. C., Warner N. L. In vitro induction of tumor-specific immunity. II. Activation of cytotoxic lymphocytes to murine oncofetal antigens. J Natl Cancer Inst. 1976 Aug;57(2):377–387. doi: 10.1093/jnci/57.2.377. [DOI] [PubMed] [Google Scholar]
  11. Dennert G., Hyman R., Lesley J., Trowbridge I. S. Effects of cytotoxic monoclonal antibody specific for T200 glycoprotein on functional lymphoid cell populations. Cell Immunol. 1980 Aug 1;53(2):350–364. doi: 10.1016/0008-8749(80)90335-4. [DOI] [PubMed] [Google Scholar]
  12. Eisen H. N., Sakato N., Hall S. J. Myeloma proteins as tumor-specific antigens. Transplant Proc. 1975 Jun;7(2):209–214. [PubMed] [Google Scholar]
  13. Fischer Lindahl K., Bocchieri M., Riblet R. Maternally transmitted target antigen for unrestricted killing by NZB T lymphocytes. J Exp Med. 1980 Dec 1;152(6):1583–1595. doi: 10.1084/jem.152.6.1583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Forman J. H-2 unrestricted cytotoxic T cell activity against antigens controlled by genes in the QA/TLA region. J Immunol. 1979 Dec;123(6):2451–2455. [PubMed] [Google Scholar]
  15. Giorgi J. V., Warner N. L. Continuous cytotoxic T cell lines reactive against murine plasmacytoma tumor-associated antigens. J Immunol. 1981 Jan;126(1):322–330. [PubMed] [Google Scholar]
  16. Herberman R. B., Djeu J., Kay H. D., Ortaldo J. R., Riccardi C., Bonnard G. D., Holden H. T., Fagnani R., Santoni A., Puccetti P. Natural killer cells: characteristics and regulation of activity. Immunol Rev. 1979;44:43–70. doi: 10.1111/j.1600-065x.1979.tb00267.x. [DOI] [PubMed] [Google Scholar]
  17. Herberman R. B., Holden H. T. Natural cell-mediated immunity. Adv Cancer Res. 1978;27:305–377. doi: 10.1016/s0065-230x(08)60936-7. [DOI] [PubMed] [Google Scholar]
  18. Herberman R. B. Natural killer cells and their possible relevance to transplantation biology. Transplantation. 1982 Jul;34(1):1–7. [PubMed] [Google Scholar]
  19. Herberman R. B., Nunn M. E., Holden H. T. Low density of Thy 1 antigen on mouse effector cells mediating natural cytotoxicity against tumor cells. J Immunol. 1978 Jul;121(1):304–309. [PubMed] [Google Scholar]
  20. Herberman R. B., Nunn M. E., Lavrin D. H. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer. 1975 Aug 15;16(2):216–229. doi: 10.1002/ijc.2910160204. [DOI] [PubMed] [Google Scholar]
  21. Kastner D. L., Rich R. R., Shen F. W. Qa-1-associated antigens. I. Generation of H-2-nonrestricted cytotoxic T lymphocytes specific for determinants of the Qa-1 region. J Immunol. 1979 Sep;123(3):1232–1238. [PubMed] [Google Scholar]
  22. Le Gros G. S., Herbert A. G., Watson J. D. In vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. II. Separation of natural killer cells and cytotoxic T cells. Immunology. 1984 Jan;51(1):103–113. [PMC free article] [PubMed] [Google Scholar]
  23. Le Gros G. S., Prestidge R. L., Watson J. D. In-vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. I. Effect of anti-Thy-1 antibody on the tissue distribution of lymphocytes. Immunology. 1983 Dec;50(4):537–546. [PMC free article] [PubMed] [Google Scholar]
  24. Lust J. A., Kumar V., Burton R. C., Bartlett S. P., Bennett M. Heterogeneity of natural killer cells in the mouse. J Exp Med. 1981 Aug 1;154(2):306–317. doi: 10.1084/jem.154.2.306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lynch R. G., Graff R. J., Sirisinha S., Simms E. S., Eisen H. N. Myeloma proteins as tumor-specific transplantation antigens. Proc Natl Acad Sci U S A. 1972 Jun;69(6):1540–1544. doi: 10.1073/pnas.69.6.1540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. MacKenzie M. R., Burton R. C., Warner N. L. Tumor immunity to murine plasma cell tumors. V. Demonstration of a unique tumor antigen that is not associated with the myeloma idiotype. Int J Cancer. 1978 Jun 15;21(6):789–795. doi: 10.1002/ijc.2910210618. [DOI] [PubMed] [Google Scholar]
  27. McCoy J. L., Dean J. H., Law L. W., Williams J., McCoy N. T., Holiman B. J. Immunogenicity, antigenicity and mechanisms of tumor rejection of mineral-oil-induced plasmacytomas in syngeneic BALB/c mice. Int J Cancer. 1974 Aug 15;14(2):264–276. doi: 10.1002/ijc.2910140216. [DOI] [PubMed] [Google Scholar]
  28. Mills G. B., Carlson G., Paetkau V. Generation of cytotoxic lymphocytes to syngeneic tumors by using co-stimulator (Interleukin 2): in vivo activity. J Immunol. 1980 Nov;125(5):1904–1909. [PubMed] [Google Scholar]
  29. Mills G. B., Paetkau V. Generation of cytotoxic lymphocytes to syngeneic tumor by using co-stimulator (Interleukin 2). J Immunol. 1980 Nov;125(5):1897–1903. [PubMed] [Google Scholar]
  30. Minato N., Reid L., Bloom B. R. On the heterogeneity of murine natural killer cells. J Exp Med. 1981 Sep 1;154(3):750–762. doi: 10.1084/jem.154.3.750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Mochizuki D. Y., Watson J., Gillis S. Biochemical separation of interleukin 2. J Immunol Methods. 1980;39(3):185–201. doi: 10.1016/0022-1759(80)90055-1. [DOI] [PubMed] [Google Scholar]
  32. Mochizuki D., Watson J., Gillis S. Biochemical and biologic characterization of lymphocyte regulatory molecules. IV. Purification of Interleukin 2 from a murine T cell lymphoma. J Immunol. 1980 Dec;125(6):2579–2583. [PubMed] [Google Scholar]
  33. Russel J. H., Hale A. H., Inbar D., Eisen H. N. Loss of reactivity of a BALB/c myeoloma tumor with allogeneic and syngeneic cytotoxic T lymphocytes. Eur J Immunol. 1978 Sep;8(9):640–645. doi: 10.1002/eji.1830080907. [DOI] [PubMed] [Google Scholar]
  34. Shustik C., Cohen I. R., Schwartz R. S., Latham-Griffin E., Waksal S. D. T lymphocytes with promiscuous cytotoxicity. Nature. 1976 Oct 21;263(5579):699–701. doi: 10.1038/263699a0. [DOI] [PubMed] [Google Scholar]
  35. Stutman O., Paige C. J., Figarella E. F. Natural cytotoxic cells against solid tumors in mice. I. Strain and age distribution and target cell susceptibility. J Immunol. 1978 Nov;121(5):1819–1826. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES